LBF20406LT08: Difference between revisions
No edit summary |
No edit summary |
||
| Line 11: | Line 11: | ||
|Chemical Synthesis= | |Chemical Synthesis= | ||
|Metabolism= | |Metabolism= | ||
|Biological Activity=12-epi LTB4 has a week agonistic character at both recombinant human BLT1 and BLT2 approximately 10 _M for complete activation.[[Reference:Yokomizo_T:Kato_K:Hagiya_H:Izumi_T:Shimizu_T:,J. Biol. Chem.,2001,276,12454|{{RelationTable/GetFirstAuthor|Reference:Yokomizo_T:Kato_K:Hagiya_H:Izumi_T:Shimizu_T:,J. Biol. Chem.,2001,276,12454}}]] | |||
}} | }} | ||
{{Lipid/Footer}} | {{Lipid/Footer}} | ||
Revision as of 06:00, 7 January 2010
| LipidBank Top (トップ) |
Fatty acid (脂肪酸) |
Glycerolipid (グリセロ脂質) |
Sphingolipid (スフィンゴ脂質) |
Journals (雑誌一覧) |
How to edit (ページの書き方) |
| IDs and Links | |
|---|---|
| LipidBank | XPR3117 |
| LipidMaps | LMFA03020015 |
| CAS | |
| KEGG | {{{KEGG}}} |
| KNApSAcK | {{{KNApSAcK}}} |
| mol | LBF20406LT08 |
| 12-epi Leukotriene B4 | |
|---|---|
| |
| Structural Information | |
| 5S,12S-dihydroxy-6Z,8E,10E,14Z-eicsatetraenoic acid | |
| |
| Formula | C20H32O4 |
| Exact Mass | 336.23005951199997 |
| Average Mass | 336.46567999999996 |
| SMILES | C(CC=CC[C@@H](C=CC=CC=C[C@@H](CCCC(O)=O)O)O)CCC |
| Physicochemical Information | |
| 12-epi LTB4 has a week agonistic character at both recombinant human BLT1 and BLT2 approximately 10 _M for complete activation. Yokomizo_T et al. | |
| Spectral Information | |
| Mass Spectra | |
| UV Spectra | |
| IR Spectra | |
| NMR Spectra | |
| Other Spectra | |
| Chromatograms | |
| Reported Metabolites, References | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
|
